COVID-19 and Diarrhea

In the earliest stages of the pandemic, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus was thought to cause diseases of the respiratory system, with the thin cells of the respiratory system providing an environment for the infection to spread among humans via the respiratory tract. Across the globe, populations were asked to remain vigilant of three classic symptoms: a fever, a new and continuous cough and shortness of breath

As the pandemic has continued, evidence that the infection can manifest in non-respiratory symptoms has grown. Currently, the Centres for Disease Control and Prevention (CDC) list eleven symptoms as indicative of COVID-19, including two gastrointestinal symptoms.

Interest in the impact of COVID-19 on the gastrointestinal system began to emerge in line with an increasing number of patients presenting with symptoms including nausea, diminished appetite and diarrhea. Early case reports demonstrated the presence of the virus in stool samples, suggestive of an additional route to transmission via the fecal-oral route.

gastrointestinalImage Credit: Explode /

Biological mechanisms for SARS-CoV-2 and gastrointestinal symptoms

It is widely accepted that the COVID-19 causing virus can enter and infect host cells via angiotensin-converting enzyme 2 (ACE-2). ACE-2 is an enzyme involved in lowering blood pressure and inflammation and is found on the surface of many cell types. The spike protein of the SARS-CoV-2 virus binds with ACE-2 on the surface of the host cell, resulting in the endocytosis of the virus and enzyme into the cell. ACE-2 is highly expressed in the upper and lower gastrointestinal tract, providing a prerequisite for SARS-Cov-2 infection.

Prevalence of diarrhea in COVID-19

Diarrhea as a symptom of COVID-19 has significant consequences for public health. The potential for the virus to be transmitted via the fecal-oral route presents additional challenges for areas with poor sanitation. Current disinfection strategies such as chlorination may prove to be insufficient against the virus.

A systematic review of gastrointestinal symptoms in COVID-19 showed an overall prevalence of diarrhea between 5 – 10%, although rates varied extensively between studies. Larger cohort studies report prevalence rates between 20-30%.

Diarrhea may be underreported

Studies that look at the prevalence of diarrhea symptoms following SARS-CoV-2 infections have reported lower rates than those observed in other coronaviruses, with studies reporting diarrhea in up to 50% of patients with SARS and 75% of patients with MERS. However, researchers believe that the currently available data may underestimate the burden of COVID-19 related diarrhea. Few studies conducted to date have included a specific criterion for describing diarrhea, neither in terms of describing the number of evacuations per day nor consistency of stools.

Studies that describe COVID-19 symptomology have tended to focus on the most critically ill patients: those who are at risk of severe illness, long-term effects, or mortality. The impact of the virus on the respiratory or circulatory systems has taken precedence over the impact of the infection on the gastrointestinal system. Furthermore, as COVID-19 testing programs and public health information programs have largely focused on describing respiratory symptoms, it is plausible to suggest that there may be a cohort of undiagnosed patients with low severity illness but with digestive symptoms, such as diarrhea.

Prognostic implications of diarrhea in COVID-19

The correlations between diarrhea and symptom severity, and diarrhea and clinical outcomes in COVID-19 still require clarification. In some cases, studies have found that diarrhea is more prevalent in patients with severe COVID-19 compared to patients with mild or moderate disease. Similarly, the presence of COVID-19 with gastrointestinal symptoms has been shown to increase the risk of acute respiratory distress syndrome and mechanical ventilation, as compared with COVID-19 without gastrointestinal symptoms. Other studies, however, have not found such associations between the presence of diarrhea and the severity of COVID-19.

The research regarding whether gastrointestinal symptoms emerge prior to, or after respiratory symptoms is also mixed. In one study conducted in the United States, patients exclusively developed diarrhea after developing the classic COVID-19 of a cough, fever, and shortness of breath.

More recently, one study identified subgroups of COVID-19 patients: one group who developed respiratory symptoms only, one group who developed both respiratory and gastrointestinal symptoms, and a final, small sub-group who developed gastrointestinal symptoms only. Patients who presented with digestive symptoms had a longer course between symptom onset and viral clearance, indicating a possible higher viral burden. Critically, these patients also took longer to seek medical care. This, teamed with an absence of respiratory symptoms, could indicate a subset of patients who may be unintentionally spreading the virus.


Healthcare staff should recognize that new-onset diarrhea could be indicative of COVID-19 infection in the absence of classic respiratory symptoms. Patients should be encouraged to quarantine and seek medical advice, especially if they have recently been in contact with another infected individual. Preventative measures against the spread of the virus should also include consideration of the oral-fecal transmission route.

Symptoms of Coronavirus Disease 2019


  • D'Amico, F., Baumgart, D. C., Danese, S., & Peyrin-Biroulet, L. (2020). Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 18(8), 1663–1672.
  • Guan, W. J., Ni, Z. Y., Hu, Y. et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine, 382(18), 1708–1720.
  • Han, C., Duan, C., Zhang, S., Spiegel, B., Shi, H., Wang, W., Zhang, L., Lin, R., Liu, J., Ding, Z., & Hou, X. (2020). Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes. The American journal of gastroenterology, 115(6), 916–923.
  • Jin, X., Lian, J. S., Hu, J. H., Gao, J., Zheng, L., Zhang, Y. M., Hao, S. R., Jia, H. Y., Cai, H., Zhang, X. L., Yu, G. D., Xu, K. J., Wang, X. Y., Gu, J. Q., Zhang, S. Y., Ye, C. Y., Jin, C. L., Lu, Y. F., Yu, X., Yu, X. P., … Yang, Y. (2020). Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut, 69(6), 1002–1009.
  • Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (New York, N.Y.), 367(6485), 1444–1448.

Further Reading

Last Updated: Apr 20, 2021

Clare Knight

Written by

Clare Knight

Since graduating from the University of Cardiff, Wales with first-class honors in Applied Psychology (BSc) in 2004, Clare has gained more than 15 years of experience in conducting and disseminating social justice and applied healthcare research.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Knight, Clare. (2021, April 20). COVID-19 and Diarrhea. News-Medical. Retrieved on June 23, 2021 from

  • MLA

    Knight, Clare. "COVID-19 and Diarrhea". News-Medical. 23 June 2021. <>.

  • Chicago

    Knight, Clare. "COVID-19 and Diarrhea". News-Medical. (accessed June 23, 2021).

  • Harvard

    Knight, Clare. 2021. COVID-19 and Diarrhea. News-Medical, viewed 23 June 2021,


  1. Elisa Jones Elisa Jones United Kingdom says:

    I do believe there may be validity and truth to this research. In early Jan-20 I had a mysterious unidentified virus whereby symptoms were fever / shivers, severe diarrhoea, full loss of appetite, heavy fatigue and light breathlessness and all symptoms lasted intensively for 2 weeks. My appetite, stool patterns and energy levels took 2 months to gradually return to normal. Whilst stools were tested at time there was no covid testing then. GP told me some viruses are not known about so whilst I accepted that it troubled me as never been so ill since having chickenpox when 30 and so when covid declared itself I started to wonder was it that? I therefore follow research based on my symptoms as I do instinctively believe that maybe it reacts with certain body types this way. But then it was too early for covid? I effectively quarantined as I was too ill to go to work for 2+ weeks and live alone so didn't appear to pass it on. All a bit of a mystery and will never know for sure but wanted to blog about it as never usually an option to. I am a 50 year old female. Keep up the research!

  2. Rachel Street Rachel Street United Kingdom says:

    There are plenty of people reporting very similar sets of symptoms prior to March 2020, and anecdotally I believe children in schools have been manifesting their covid infections as sickness, diarrhoea and headaches, but have not been tested until now. Yes please continue the research and also can anyone tell me, if you have the virus in your gut with stomach pains and diarrhoea, is it clear that a nose/throat swab test will pick it up? Is it possible that you have the virus in your gut, but do not have enough viral load in your respiratory pathway to show as a positive case?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
SARS-CoV-2 oral vaccine booster shows promise in animal tests